granted
on 31 Oct 2024
Last Applicant/ Owned by
211 Carnegie Center Drive
Princeton
NJ
08540
Serial Number
97753516 filed on 13th Jan 2023
Registration Number
N/A
Correspondent Address
Peter J. Riebling
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Software as a service (SAAS) services featuring software for capturing information concerning reactions and events resulting from the use of medication and/or pharmaceuticals, for enabling follow up questions and answers regarding said reactions and events and for producing reports regarding such reactions and events; providing temporary use of on-line non-downloadable software which enables the c Read More
Consultancy services in the field of regulatory compliance and regulatory compliance auditing in the pharmaceutical field
N/A
N/A
Software as a service (SAAS) services featuring software for capturing information concerning reactions and events resulting from the use of medication and/or pharmaceuticals, for enabling follow up questions and answers regarding said reactions and events and for producing reports regarding such reactions and events; providing temporary use of on-line non-downloadable software which enables the capture of information concerning reactions and events resulting from the use of medication and/or pharmaceuticals, as well as enabling follow-up questions and answers regarding said quality, reactions and events and enables the production of reports regarding said reactions and events; maintenance of computer software which enables the capture of information concerning reactions and events resulting from the use of medication and/or pharmaceuticals and enables follow-up questions and answers regarding said reactions and events; Scientific and technological services, namely, scientific research and design in the fields of drug and pharmaceutical safety testing, pharmacovigilance, clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance; providing medical research information; medical research and product development; design and development of computer software; pharmacovigilance services for others, namely, scientific research and analysis pertaining to adverse events and product quality complaints regarding pharmaceutical products, assessment of risks presented by certain pharmaceutical products or combinations thereof, and product safety testing and consultation related thereto in the field of pharmaceuticals; Medical and scientific research, namely, conducting clinical trials; Medical and scientific research, namely, conducting clinical trials for pharmaceutical and biotechnology products; providing medical and scientific research information in the field of drug and pharmaceutical safety testing, pharmacovigilance, clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance; inspection of medicines; drug safety, namely, product quality testing and evaluation; Pharmaceutical drug development services; testing of medicines and vaccines; inspection of medicines and vaccines; information technology consulting services relating to installation, maintenance and repair of computer software for the pharmaceutical, biotechnology and healthcare industries; providing scientific information about the results of clinical trials; consultancy services in the fields of drug and pharmaceutical safety testing, medical and scientific research for clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance and pharmacovigilance, namely scientific research and analysis pertaining to adverse events and product quality complaints regarding pharmaceutical products, assessment of risks presented by certain pharmaceutical products or combinations thereof, and product safety testing and consultation related thereto in the field of pharmaceuticals; Software as a service (SaaS) featuring software for use in data processing in drug and pharmaceutical safety testing, pharmacovigilance, namely, monitoring the effects of medical drugs, data processing in clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting for drugs; Providing on-line non-downloadable software using artificial intelligence for use in data processing in drug and pharmaceutical safety testing, pharmacovigilance, namely, monitoring the effects of medical drugs, data processing in clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting for drugs; information, advisory and consultancy services relating to all the aforesaid
N/A
N/A
Educational services, namely, classes, seminars and training in the fields of drug and pharmaceutical safety testing, pharmacovigilance clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting; conducting seminars and workshops in the fields of drug and pharmaceutical safety testing, pharmacovigilance, clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting; publication of books; publication of electronic books and journals on-line; providing on-line non-downloadable electronic publications, namely, books, magazines, journals, texts and documents in the fields of drug and pharmaceutical safety testing, pharmacovigilance, clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting; information, advisory and consultancy services relating to all the aforesaid
N/A
N/A
Outsourcing services, namely, arranging of service contracts and procurement of goods or services for others; business consultancy; business consulting, business assistance, and business management in the fields of drug and pharmaceutical safety testing, pharmacovigilance, clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting; database management in the field of drug and pharmaceutical safety testing, pharmacovigilance clinical trials, and capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting; information, advisory and consultancy services relating to all the aforesaid
N/A
N/A
Downloadable computer software for capturing information concerning reactions and events resulting from the use of medication and/or pharmaceuticals, enabling follow-up questions and answers regarding said reactions and events and producing reports regarding such reactions and events; downloadable computer programs for capturing information concerning reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such reactions and events; downloadable computer software applications for capturing information concerning reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such reactions and events; Downloadable computer software and downloadable computer software applications for use in data processing in drug and pharmaceutical safety testing, pharmacovigilance, namely, monitoring the effects of medical drugs, data processing in clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting for drugs
N/A
N/A
No 97753516
No Service Mark
No 000257-00076
Yes
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
31st Oct 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
31st Oct 2024 | SOU EXTENSION 1 FILED |
31st Oct 2024 | SOU EXTENSION 1 GRANTED |
31st Oct 2024 | SOU TEAS EXTENSION RECEIVED |
07th May 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
12th Mar 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
12th Mar 2024 | PUBLISHED FOR OPPOSITION |
21st Feb 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
21st Feb 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
01st Feb 2024 | ELECTRONIC RECORD REVIEW COMPLETE |